Deval Deepak Zaveri, MBBS

Deval Zaveri practices at Caremind Health in Silver Spring, Maryland.

Deval Zaveri's NPI, 1245407477, was assigned on May 16, 2008. Deval Zaveri holds Maryland license D90470.

Deval Zaveri's primary practice is Caremind Health, at 8040 Georgia Ave Suite 170 Suite 170, Silver Spring, MD 20910-4959. The practice phone is (202) 360-4787.

Deval Zaveri's primary practice is Caremind Health in Silver Spring, Maryland. Deval Zaveri is also affiliated with University of Maryland Capital Region Medical Center. The medical group on file is CareMind Health. Dmand AI also links Deval Zaveri to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Deval Zaveri practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Deval Zaveri's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dmand AI has Deval Zaveri's licenses on file in 2 states: Maryland and New York.

CMS data shows 94 Medicare services from Deval Zaveri across 3 procedure codes in 2024, for 76 Medicare patients. Medicare paid $10,846 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 76 Medicare patients who saw Deval Zaveri in 2024. The largest group is under 65, with 30 patients. 75% of them have anxiety, and 75% have depression. 55% are also on Medicaid. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Deval Zaveri's median patient age at 34, with 28% women.

In 2024, Deval Zaveri wrote 58 Medicare Part D claims for 18 patients. 98% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $95 in total drug cost. In 2023, CMS named 220 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 66 out of 100 for Deval Zaveri for performance year 2024, reported as part of a group. Deval Zaveri accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Deval Zaveri, published from 2018 to 2019. Deval Zaveri's most frequent co-authors are Saeed Ahmed, MD, Navjot Kaur Brainch, MBBS and Sanya Virani, MD, MPH.

CMS Open Payments shows 10 general payments to Deval Zaveri from 4 drug and device companies from 2016 to 2020. Food and beverage make up the largest share, 100% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $368.